Patent number: 7541339
Abstract: The present invention relates to a peptide derivative represented by the general formula (I) or a salt thereof: Z-(CH2)n—CO—NH-Leu-Ile-Gly-AA1-AA2-CO—R (I) wherein Z represents an aryl group which may or may not have a substituent or a heteroaryl group which may or may not have a substituent; n represents 0, 1 or 2: AA1-AA2 represents Lys-Val or Arg-Leu; and R represents —OH or —NH2, and relates to a pharmaceutical composition comprising a peptide derivative represented by the general formula (I) or a salt thereof, and a pharmaceutically acceptable carrier thereof. The peptide derivative is useful as a prophylactic and therapeutic agent of dysfunction of masticatory, dysphagia, dysgeusia, ozostomia, intra-oral cavity dysphoria, intra-oral cavity infections, intra-oral cavity inflammations, dry eye, ectocornea detachment, keratitis, corneal ulcer, conjunctivitis, stomach ulcer, duodenal ulcer, gastritis, diarrhea, enteritis or Sjogren's syndrome.
Type:
Grant
Filed:
June 10, 2003
Date of Patent:
June 2, 2009
Assignees:
The University of Edinburgh, The University of Strathclyde, Kowa Company, Ltd.
Inventors:
Robert Ramage, Robin Plevin, Kevin Thomas Shaw, Lu Jiang, Louise Claire Young, Alan Lang Harvey, Pu Wang, Toru Kanke, Junichi Kawagoe, Mototsugu Kabeya